Seth Cohen - 16 Oct 2023 Form 4 Insider Report for DMK PHARMACEUTICALS Corp

Reporting relationship: CFO
Issuer ticker: N/A
Reported as of: 16 Oct 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Oct 2023, 17:18:34 UTC
Source filing: View source filing
Reporting owner signature: /s/ Seth A.Cohen

Key filing fact

Seth Cohen filed Form 4 for DMK PHARMACEUTICALS Corp on 25 Oct 2023.

Key facts

This page summarizes Seth Cohen's Form 4 filing for DMK PHARMACEUTICALS Corp.
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 25 Oct 2023, 17:18.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DMK transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +151,416
Change %
Price: $0.000000
Shares after: 151,416
Date: 16 Oct 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 151,416
Exercise price: $0.6016
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests and becomes exercisable as to 1/8 of the total number of shares subject to the option on the six-month anniversary of the grant date and thereafter monthly with respect to 1/48 of the total number of shares subject to the option.